These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 21576437)

  • 1. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone.
    Ohnishi M; Golparian D; Shimuta K; Saika T; Hoshina S; Iwasaku K; Nakayama S; Kitawaki J; Unemo M
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3538-45. PubMed ID: 21576437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.
    Unemo M; Golparian D; Nicholas R; Ohnishi M; Gallay A; Sednaoui P
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1273-80. PubMed ID: 22155830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance.
    Shimuta K; Unemo M; Nakayama S; Morita-Ishihara T; Dorin M; Kawahata T; Ohnishi M;
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5225-32. PubMed ID: 23939890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence and evolution of internationally disseminated cephalosporin-resistant Neisseria gonorrhoeae clones from 1995 to 2005 in Japan.
    Shimuta K; Watanabe Y; Nakayama S; Morita-Ishihara T; Kuroki T; Unemo M; Ohnishi M
    BMC Infect Dis; 2015 Sep; 15():378. PubMed ID: 26381611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea.
    Lee H; Unemo M; Kim HJ; Seo Y; Lee K; Chong Y
    J Antimicrob Chemother; 2015 Sep; 70(9):2536-42. PubMed ID: 26084303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.
    Thakur SD; Starnino S; Horsman GB; Levett PN; Dillon JR
    J Antimicrob Chemother; 2014 Jun; 69(6):1510-6. PubMed ID: 24532681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.
    Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M
    J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?
    Unemo M; Golparian D; Limnios A; Whiley D; Ohnishi M; Lahra MM; Tapsall JW
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3603-9. PubMed ID: 22547617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissemination and genome analysis of high-level ceftriaxone-resistant
    Lin X; Chen W; Xie Q; Yu Y; Liao Y; Feng Z; Qin X; Wu X; Tang S; Zheng H
    Emerg Microbes Infect; 2022 Dec; 11(1):344-350. PubMed ID: 34994305
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular characterization of Neisseria gonorrhoeae isolates collected through a national surveillance programme in Japan, 2013: evidence of the emergence of a ceftriaxone-resistant strain from a ceftriaxone-susceptible lineage.
    Hanao M; Aoki K; Ishii Y; Shimuta K; Ohnishi M; Tateda K
    J Antimicrob Chemother; 2021 Jun; 76(7):1769-1775. PubMed ID: 33930160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA.
    Gose S; Nguyen D; Lowenberg D; Samuel M; Bauer H; Pandori M
    BMC Infect Dis; 2013 Dec; 13():570. PubMed ID: 24305088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.
    Li S; Su XH; Le WJ; Jiang FX; Wang BX; Rice PA
    BMC Infect Dis; 2014 Nov; 14():622. PubMed ID: 25427572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010.
    Martin I; Sawatzky P; Allen V; Hoang L; Lefebvre B; Mina N; Wong T; Gilmour M
    Sex Transm Dis; 2012 Apr; 39(4):316-23. PubMed ID: 22421701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance and molecular characterisation of Neisseria gonorrhoeae isolates in Fukuoka, Japan, 1996-2016.
    Tanaka M; Furuya R; Kobayashi I; Kanesaka I; Ohno A; Katsuse AK
    J Glob Antimicrob Resist; 2019 Jun; 17():3-7. PubMed ID: 30448519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of amino acids conferring high-level resistance to expanded-spectrum cephalosporins in the penA gene from Neisseria gonorrhoeae strain H041.
    Tomberg J; Unemo M; Ohnishi M; Davies C; Nicholas RA
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3029-36. PubMed ID: 23587946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.
    Cámara J; Serra J; Ayats J; Bastida T; Carnicer-Pont D; Andreu A; Ardanuy C
    J Antimicrob Chemother; 2012 Aug; 67(8):1858-60. PubMed ID: 22566592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
    Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
    J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced gonococcal antimicrobial surveillance in the era of ceftriaxone resistance: a real-time PCR assay for direct detection of the Neisseria gonorrhoeae H041 strain.
    Goire N; Ohnishi M; Limnios AE; Lahra MM; Lambert SB; Nimmo GR; Nissen MD; Sloots TP; Whiley DM
    J Antimicrob Chemother; 2012 Apr; 67(4):902-5. PubMed ID: 22207596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.
    Gianecini R; Romero MLM; Oviedo C; Vacchino M; Galarza P;
    Sex Transm Dis; 2017 Jun; 44(6):351-355. PubMed ID: 28499284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
    Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
    BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.